XENE Stock-Based Compensation
Xenon Pharmaceuticals Inc · Stock-Based Compensation
XENE Stock-Based Compensation
Latest reported$61.45Mperiod ending
XENE TTM Stock-Based Comp ($605.00K → $61.45M)
TTM stock-based compensation
High-resolution chart · PNG
XENE stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 61,446,000 | |
| 58,427,000 | |
| 53,707,000 | |
| 53,191,000 | |
| 52,488,000 | |
| 53,491,000 | |
| 50,717,000 | |
| 46,300,000 | |
| 42,041,000 | |
| 35,778,000 | |
| 32,372,000 | |
| 29,002,000 | |
| 26,001,000 | |
| 22,756,000 | |
| 20,376,000 | |
| 17,269,000 | |
| 14,170,000 | |
| 11,666,000 | |
| 10,017,000 | |
| 8,922,000 | |
| 6,279,000 | |
| 3,575,000 | |
| 2,625,000 | |
| 2,372,000 | |
| 2,984,000 | |
| 3,448,000 | |
| 2,924,000 | |
| 2,142,000 | |
| 2,217,000 | |
| 2,453,000 | |
| 2,625,000 | |
| 2,643,000 | |
| 2,523,000 | |
| 2,421,000 | |
| 2,236,000 | |
| 2,162,000 | |
| 2,231,000 | |
| 2,047,000 | |
| 2,161,000 | |
| 2,116,000 | |
| 1,289,000 | |
| 4,033,000 | |
| 3,729,000 | |
| 3,454,000 | |
| 3,833,000 | |
| 862,000 | |
| 760,000 | |
| 742,000 | |
| 705,000 | |
| 654,500 | |
| 605,000 | |
| 525,000 | |
| 475,000 |